Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Syneron Medical Ltd (NASDAQ:ELOS)

6.63
Delayed Data
As of Aug 29
 +0.19 / +2.95%
Today’s Change
6.10
Today|||52-Week Range
9.63
-14.01%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$223.5M

Company Description

Syneron Medical Ltd. engages in the provision of aesthetic medical treatment. Its activities include design, development and marketing of aesthetic medical products using technologies such as Electro-Optical Synergy, a technology which uses the synergy between electrical energy, including radiofrequency and optical energy. It operates through the Professional Aesthetic Devices (PAD) and Emerging Business Unit (EBU) segments. The PAD segment includes research, development, marketing, and sale of aesthetic medical equipment for the treatment of body and face for dermatologists, plastic surgeons and other practitioners. The EBU segment consists of non-professional aesthetic devices products which targets home-use consumers, and other emerging businesses. The company was founded by Shimon Eckhouse and Moshe Mizrahy in July 2000 and is headquartered in Yokneam Illit, Israel.

Contact Information

Syneron Medical Ltd.
Industrial Zone
Yokneam Illit Haifa 20692
P:972732442200
Investor Relations:

Employees

Shareholders

Other institutional53.36%
Mutual fund holders24.12%
Individual stakeholders10.08%

Top Executives

Amit MeridorPresident & Chief Executive Officer
Shlomo AlkalayChief Operating Officer
Hugo GoldmanChief Financial Officer
Sarit Soccary Ben YochananVice President-Strategy & Business Development
Erik DowellPresident-Americas